Funding round
Resilience Series C
Resilience, which works in biologics manufacturing in Blue Ash, raised $600M in a Series C round announced on 1 Aug 2021. It is Resilience's second venture round on record; the one before was a Series B in Nov 2020.
$600M
Amount raised
Not disclosed
Post-money valuation
Valuation
What this round says about the price
Resilience did not disclose a valuation in this round. It came 9 months after Resilience's Series B. It is 30% of the $2.02B Resilience has raised in the venture rounds on record. Resilience raised again 10 months later: a Series D round of $625M in Jun 2022.
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, geographic expansion, scaling operations, acquisitions and working capital.
- Product development
- Geographic expansion
- Scaling operations
- Acquisitions
- Working capital
Comparable rounds
How it compares
30 Series C rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $52M, and this round was 12 times the median. The closest in time, other companies' Series C rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Formation Bio Pharmaceutical Products | 30 Sep 2021 | $156M | not disclosed | Sam Altman and Lachy Groom |
| Pharmaceutical Products | 27 Jul 2021 | $153M | not disclosed | Omega Funds and TCG Crossover |
| Pharmaceutical Products | 15 Sep 2021 | $60M | not disclosed | Arboretum Ventures |
| Pharmaceutical Products | 15 Jun 2021 | $108M | not disclosed | Venrock |
| Pharmaceutical Products | 13 Oct 2021 | $70M | not disclosed | IDG Capital and Loyal Valley Capital |
| Pharmaceutical Products | 16 Jun 2021 | $66M | not disclosed | The Column Group and Nextech Invest |
| Pharmaceutical Products | 24 Jun 2021 | $61M | not disclosed | AIG Investments |
| Pharmaceutical Products | 13 Oct 2021 | $37M | not disclosed | OneVentures and UTokyo IPC |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Resilience raise in its Series C round?
Resilience raised $600M in its Series C round, announced in Aug 2021.
What was Resilience's valuation at the Series C round?
It was not disclosed.
How does it compare with other Series C rounds in Pharmaceutical Products?
30 Series C rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $52M, and this round was 12 times the median.
Did Resilience raise again after this round?
Yes: a Series D round in Jun 2022 of $625M.